DIVA Laboratories, Ltd. (TPEX:4153)

Market Cap	1.77B -16.0%
Revenue (ttm)	946.04M +9.7%
Net Income	115.04M +37.1%
EPS	1.95 +37.4%
Shares Out	58.67M
PE Ratio	15.50
Forward PE	n/a
Dividend	2.00 (6.61%)
Ex-Dividend Date	Jun 12, 2026

Volume	1,094,434
Open	30.95
Previous Close	30.95
Day's Range	30.25 - 31.90
52-Week Range	29.00 - 36.40
Beta	0.26
Analysts	n/a
Price Target	n/a
Est. Earnings	Mar 12, 2027

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the research, development, manufacture, and sale of medical devices and computer peripherals worldwide. The company provides endo/surgical displays for hybrid and other types of OR applications; color and mono displays for radiology applications; and touch and embedded display, as well as industrial displays. DIVA Laboratories, Ltd. was founded in 1984 and is headquartered in New Taipei City, Taiwan.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1984
• Employees: 154
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4153

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 6, 2026

Data Sources Report a data error